Dr. Westmoreland is a physician/scientist specializing in the the field of Pediatric Hematology Oncology.
Education and Training
BS, Wake Forest University
MD, Wake Forest University, School of Medicine
Residency in Pediatrics, University of Utah, Primary Children’s Medical Center
Fellowship in David N. Pincus Global Health Program, Children’s Hospital of Philadelphia, Gaborone, Botswana
Global Health Fellow, UNC-Project Malawi, University of North Carolina/National Institutes of Health, Fogarty International Lilongwe, Malawi
Fellowship in Pediatric Hematology Oncology, University of North Carolina Hospitals
T32 Fellowship, UNC-Duke Clinical Pharmacology, University of North Carolina Hospitals
Research
Dr. Westmoreland is a PI for several studies in pediatric cancer and sickle cell disease in Malawi and is based full time at UNC Project-Malawi. She was awarded the prestigious Fogarty K-01 International Research Scientist Development Award (IRSDA) (2019-2024), which is a career development award that supports her research to improve the understanding of chemotherapy pharmacokinetics and patient-reported health-related quality of life outcomes in pediatric and adolescent Burkitt Lymphoma patients, with a special emphasis on malnutrition.
Dr. Westmoreland is a leading expert in translating and validating pediatric patient-reported outcomes (PROs) tools for use in Sub-Saharan Africa to measure health-related quality of life (PROMIS) and subjective adverse events (PRO-CTCAE), and incorporating these tools into research studies and clinical trials. In 2020, she received a one-year, $500,000 NIH grant to build clinical and research capacity in Malawi to better diagnose and treat children with sickle cell disease. She is also passionate about mentoring junior clinician scientists in Malawi and serves as a mentor for numerous UJMT Fogarty fellows and is the PRO training core director for our NIH D43 M-CORP (Malawi Cancer Research Outcomes Program) training grant.
